Antibodies that neutralize multiple flu strains (N&V)
Nature Structural & Molecular Biology
February 23, 2009
Researchers have engineered human antibodies that protect animals against lethal doses of multiple strains of influenza virus. These antibodies, described online this week in Nature Structural & Molecular Biology, work with a broad array of influenza viral strains, including H5N1 avian flu and the H1N1 1918 Spanish flu.
After illness or vaccination, the body normally produces antibodies to protect itself from a future flu attack, but these antibodies usually neutralize only the same virus strain that infected it.
Wayne Marasco and colleagues selected broadly neutralizing antibodies against an influenza protein called hemagglutinin. Hemagglutinin anchors the virus to the host cells and promotes viral fusion, effectively allowing the virus to invade the cell. The antibodies prevented viral fusion by recognizing a region of hemagglutinin that is not very visible to the immune system and that does not show large variability among strains. In this way the antibodies were able to bind to 8 of the 16 existing types of influenza hemagglutinin tested.
In an accompanying News & Views article, Peter Palese says the work indicates that "a universal immune-based treatment or vaccine may not be out of reach".
[
doi: 10.1038/nsmb.1566
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports